Diality is a Series-B stage, privately owned company that has raised $59.5M to date with the close of Series B, Tranche II in Q3 of 2020.

Press Release

IRVINE, Calif., Oct. 20, 2020 /PRNewswire/ -- Diality Inc (, a medical device company that is developing a versatile hemodialysis system to address the unmet technology needs of the evolving dialysis industry, announced the close of a $12.5 million Series B investment round... Read the full press release here.

If you are interested in learning more about potential investment opportunities, please contact us below.

*Required fields.

Thanks for contacting Diality. If you subscribed, please confirm by clicking the link in the email we just sent.